Xiaoshan M Shao

ORCID

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Venues

Nature medicine

Nature machine intelligence

This page only lists publications with an associated author ORCID identifier.

Publications

Noushin Niknafs, Archana Balan, Christopher Cherry, Karlijn Hummelink, Kim Monkhorst, Xiaoshan M Shao, Zineb Belcaid, Kristen A Marrone, Joseph C Murray, Kellie N Smit, Benjamin Levy, Josephine Feliciano, Christine L Hann, Vincent Lam, Drew M Pardoll, Rachel Karchin, Tanguy Y Seiwert, Julie R Brahmer, Patrick M Forde, Victor E Velculescu, Valsamo Anagnostou
Persistent mutation burden drives sustained anti-tumor immune responses. Nature medicine 29 (2) (2023)
Noushin Niknafs, Archana Balan, Christopher Cherry, Karlijn Hummelink, Kim Monkhorst, Xiaoshan M Shao, Zineb Belcaid, Kristen A Marrone, Joseph C Murray, Kellie N Smit, Benjamin Levy, Josephine Feliciano, Christine L Hann, Vincent Lam, Drew M Pardoll, Rachel Karchin, Tanguy Y Seiwert, Julie R Brahmer, Patrick M Forde, Victor E Velculescu, Valsamo Anagnostou
Persistent mutation burden drives sustained anti-tumor immune responses. Nature medicine (2023)
Benjamin Alexander Albert, Yunxiao Yang, Xiaoshan M Shao, Dipika Singh, Kellie N Smit, Valsamo Anagnostou, Rachel Karchin
Deep neural networks predict class I major histocompatibility complex epitope presentation and transfer learn neoepitope immunogenicity. Nature machine intelligence 5 (8) (2023)
Noushin Niknafs, Archana Balan, Christopher Cherry, Karlijn Hummelink, Kim Monkhorst, Xiaoshan M Shao, Zineb Belcaid, Kristen A Marrone, Joseph C Murray, Kellie N Smit, Benjamin Levy, Josephine Feliciano, Christine L Hann, Vincent Lam, Drew M Pardoll, Rachel Karchin, Tanguy Y Seiwert, Julie R Brahmer, Patrick M Forde, Victor E Velculescu, Valsamo Anagnostou
Persistent mutation burden drives sustained anti-tumor immune responses. Nature medicine (2023)
Noushin Niknafs, Archana Balan, Christopher Cherry, Karlijn Hummelink, Kim Monkhorst, Xiaoshan M Shao, Zineb Belcaid, Kristen A Marrone, Joseph C Murray, Kellie N Smit, Benjamin Levy, Josephine Feliciano, Christine L Hann, Vincent Lam, Drew M Pardoll, Rachel Karchin, Tanguy Y Seiwert, Julie R Brahmer, Patrick M Forde, Victor E Velculescu, Valsamo Anagnostou
Persistent mutation burden drives sustained anti-tumor immune responses. Nature medicine 29 (2) (2023)
Noushin Niknafs, Archana Balan, Christopher Cherry, Karlijn Hummelink, Kim Monkhorst, Xiaoshan M Shao, Zineb Belcaid, Kristen A Marrone, Joseph C Murray, Kellie N Smit, Benjamin Levy, Josephine Feliciano, Christine L Hann, Vincent Lam, Drew M Pardoll, Rachel Karchin, Tanguy Y Seiwert, Julie R Brahmer, Patrick M Forde, Victor E Velculescu, Valsamo Anagnostou
Persistent mutation burden drives sustained anti-tumor immune responses. Nature medicine 29 (2) (2023)
Noushin Niknafs, Archana Balan, Christopher Cherry, Karlijn Hummelink, Kim Monkhorst, Xiaoshan M Shao, Zineb Belcaid, Kristen A Marrone, Joseph C Murray, Kellie N Smit, Benjamin Levy, Josephine Feliciano, Christine L Hann, Vincent Lam, Drew M Pardoll, Rachel Karchin, Tanguy Y Seiwert, Julie R Brahmer, Patrick M Forde, Victor E Velculescu, Valsamo Anagnostou
Persistent mutation burden drives sustained anti-tumor immune responses. Nature medicine 29 (2) (2023)
Noushin Niknafs, Archana Balan, Christopher Cherry, Karlijn Hummelink, Kim Monkhorst, Xiaoshan M Shao, Zineb Belcaid, Kristen A Marrone, Joseph C Murray, Kellie N Smit, Benjamin Levy, Josephine Feliciano, Christine L Hann, Vincent Lam, Drew M Pardoll, Rachel Karchin, Tanguy Y Seiwert, Julie R Brahmer, Patrick M Forde, Victor E Velculescu, Valsamo Anagnostou
Persistent mutation burden drives sustained anti-tumor immune responses. Nature medicine 29 (2) (2023)
Patrick M Forde, Valsamo Anagnostou, Zhuoxin Sun, Suzanne E Dahlberg, Hedy L Kindler, Noushin Niknafs, Thomas Purcell, Rafael Santana-Davila, Arkadiusz Z Dudek, Hossein Borghaei, Mara Lanis, Zineb Belcaid, Kellie N Smith, Archana Balan, James R White, Christopher Cherry, I K Ashok Sivakumar, Xiaoshan M Shao, Hok Yee Chan, Dipika Singh, Sampriti Thapa, Peter B Illei, Drew M Pardoll, Rachel Karchin, Victor E Velculescu, Julie R Brahmer, Suresh R Ramalingam
Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial. Nature medicine 27 (11) (2021)

Xiaoshan M Shao.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xiaoshan M Shao